Clinical Insights in Myelofibrosis: Addressing Unmet Needs & Advancing Outcomes - Episode 5

Practice Takeaways: Treating MF Patients—Key Strategies for Community Providers

December 25, 2024

Panelists share their closing thoughts and practice pearls, offering key insights and takeaways for community oncologists based on discussing treatment strategies in myelofibrosis.

EP. 1: Clinical Perspectives: Firstline Treatment Landscape in Higher-Risk MF

EP. 2: Tackling Complex Clinical Scenarios: MF Patients With Thrombocytopenia and Anemia

EP. 3: Challenges With Defining “Ruxolitinib Failure” or Suboptimal Response to Ruxolitinib in MF

EP. 4: Clinical Insights on Managing Ruxolitinib Cytopenias: Patient-Focused Approach

Now Viewing

EP. 5: Practice Takeaways: Treating MF Patients—Key Strategies for Community Providers

Dr Kuykendall: Thank you to Dr Konala for this insightful discussion. Before we end, I would like to get some closing thoughts or practice pearls you wish to share with your community colleagues from what we’ve discussed today.